Journal Browser Advanced Search Help
Journal Browser Advanced search HELP
Clin Endosc. 2018 Nov;51(6):584-586. English. Case Report. https://doi.org/10.5946/ce.2018.038
Reed L , Edriss H , Nugent K .
Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, USA. kenneth.nugent@ttuhsc.edu
Abstract

Obesity in the United States is a medical crisis with many people attempting to lose weight with caloric restriction. Some patients choose minimally invasive weight loss solutions, such as intragastric balloon systems. These balloon systems were approved by the Federal Drug Administration (FDA) in 2015–2016 and have been considered safe, with minimal side effects. We report a patient with a two-day history of melena, abdominal pain, hypotension, and syncope which developed five months after placement of an intragastric balloon. Esophagogastroduodenoscopy with balloon removal revealed a small 8-mm gastric ulcer in the incisura. This gastric ulcer probably developed secondary to mechanical compression of the stomach mucosa by the gastric balloon which contained 900 mL of saline. The FDA is now investigating five deaths since 2016 associated with these second-generation balloons. Clinicians should be aware of these complications when evaluating patients with gastrointestinal complications, such as bleeding.

Copyright © 2019. Korean Association of Medical Journal Editors.